UHS Stock Analysis — Universal Health Services
Sector: Healthcare
AI Verdict
UHS trades at a rock-bottom 6.9x next year's earnings, but with just 2% EPS growth expected, the market is skeptical that its hospital moat will translate into better profits soon.
Competitive Moat
Universal Health Services operates acute care hospitals and behavioral health facilities, benefiting from high regulatory barriers and local market dominance in many regions. The moat is reinforced by the complexity of hospital licensing and the difficulty for new entrants to replicate its scale and payer relationships.
Summary
UHS trades at just 6.9x forward earnings, making it one of the cheapest stocks in the healthcare sector despite steady revenue growth.
Where It Stands
UHS is down -3.85% over the past year, with an RSI of 68.4 signaling elevated pullback risk, and trades at 6.9x forward earnings versus a healthcare sector median of 22x.
Key Metrics
- RSI: 68.4 — Near Overbought
- Trailing P/E: 7.0x
- Forward P/E: 6.9x
- PEG Ratio: 59.00
- Earnings Growth: +0.0%
- Revenue Growth: +0.1%
- Market Cap: $10.1B
- Dividend Yield: 0.00%
- 1-Year Return: -3.85%
- 52-Week High: $246.33
- 52-Week Low: $140.08
Analyst Consensus
9 Buy · 16 Hold · 1 Sell (26 analysts)
Bull Case
The stock's 6.9x forward P/E is extremely low for a company with 10.1% trailing revenue growth, offering value if margins hold steady.
Bear Case
With only 2.0% forward EPS growth expected and an RSI of 68.4, any P/E compression or RSI mean reversion could drive further downside despite the low multiple.
Catalyst to Watch
Quarterly earnings that show margin improvement or outperformance on EPS growth could justify a higher valuation.